This article examines emerging non-opioid strategies for chronic pain, from targeted ion-channel drugs and anti-inflammatory ...

New drugs approved in 2025 are poised to significantly improve the management of motion sickness, acute pain, urinary tract infections (UTIs), and chronic spontaneous urticaria. Gerald W. Smetana, MD, ...

The medication, suzetrigine (JOURNAVX (R) ), was FDA-approved in January 2025 and became available at HSS in April 2025. It is the first non-opioid pain reliever released in more than 25 years.

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

Add Yahoo as a preferred source to see more of our stories on Google. Suzetrigine is a prescription pill taken every 12 hours after a larger starter dose. (Vertex Pharmaceuticals) The US Food and Drug ...

Non-opioid pain medications can treat many common causes of acute pain. They are safer and easier to get than opioids. Opioids can be addictive, may lose effectiveness over time, and require a ...

Back pain that Tylenol and ibuprofen can’t get rid of may require alternative treatment such as targeted exercises, prescription medications, or surgery. For many, back pain is an occasional annoyance ...

Researchers at VIB, VUB, and KU Leuven have identified a tiny binding site, a molecular "keyhole," in the TRPM3 ion channel, ...

Most war amputees experience steady improvements in pain, psychological symptoms and quality of life over time, according to ...